Form 4: Privia Health GC Edward Fargis Granted 28,268 RSUs

Privia Health Group's EVP & General Counsel, Edward C. Fargis, was granted 28,268 restricted stock units under the company's 2021 Omnibus Incentive Plan.

Summary

• Edward C. Fargis, EVP & General Counsel of Privia Health Group, Inc. (PRVA), acquired 28,268 shares of common stock in the form of restricted stock units (RSUs).
• The transaction occurred on March 10, 2026, with a reported price of $0 per share, indicating a grant rather than a purchase.
• These RSUs are part of the company's 2021 Omnibus Incentive Plan.
• The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of the grant date, contingent on continued service.
• Following this transaction, Mr. Fargis beneficially owns 111,979 shares directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive alignment with shareholder interests through long-term equity incentives, which is a standard and healthy corporate governance practice.

Positives

• The grant of restricted stock units aligns management's interests with long-term shareholder value through equity ownership.
• The transaction was pre-planned under a Rule 10b5-1(c) plan, indicating a structured approach to equity compensation.

Risks

• The vesting of these restricted stock units is contingent upon Edward C. Fargis's continued service to Privia Health Group, Inc.

Future Outlook

The vesting schedule for the restricted stock units indicates a commitment to retaining key executives over a three-year period, aligning their incentives with the company's long-term performance.

Management Comments

• Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.

Industry Context

StockSavvy.ai notes that equity grants, particularly restricted stock units, are a standard practice in the healthcare technology and services sector to attract, retain, and incentivize senior executives. This aligns with common industry compensation strategies aimed at fostering long-term commitment and performance.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) with a multi-year vesting schedule is a common practice for executive compensation in the healthcare and technology sectors, similar to companies like Teladoc Health (TDOC) or Amwell (AMWL), which frequently utilize such plans to align executive incentives with long-term shareholder value.
• The grant size of 28,268 RSUs for an EVP & General Counsel is within the typical range for a company of Privia Health Group's market capitalization and stage, comparable to grants observed at peer companies such as Evolent Health (EVH) or R1 RCM (RCM).
• The $0 price for the acquisition of RSUs is standard, as these are grants of future equity rather than open market purchases, reflecting a compensation award rather than an investment transaction.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact due to increased alignment of executive interests with long-term company performance and value creation.
• Employees: May signal stability in executive leadership and a commitment to long-term incentive programs.

Next Steps

• First installment of 28,268 RSUs vests on March 10, 2027, subject to continued service.
• Second installment of 28,268 RSUs vests on March 10, 2028, subject to continued service.
• Third installment of 28,268 RSUs vests on March 10, 2029, subject to continued service.

Key Dates

Recommendation

This Form 4 reports a routine equity grant to a senior executive as part of their compensation package, which is a standard practice for aligning management incentives with long-term shareholder value. While positive for governance, it does not present new information that would fundamentally alter the investment thesis or warrant a change in an existing position. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive operational or financial updates.

Keywords

Privia Health Group, PRVA, Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Compensation, Executive Compensation, Edward C. Fargis, General Counsel, 10b5-1 Plan